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Objectives: To catalogue patients with DSD and to assess the concordance of genotype and phenotype with sex
assignment at birth compared to sex assignment before and following assessment by a Gender Medicine Team
(GMT) at one institution, as an initial step in formulating standardized guidelines for management of these
conditions.
Design: After obtaining IRB approval, a retrospective chart review was conducted patients seen in the Gender
Medicine Clinic (GMC) between 2006–2009 at Texas Children’s Hospital (TCH), Houston, Texas. McNemar’s test and
Kappa agreement provided associations of various factors with sex assignment at birth prior to GMT assessment
and after GMT assessment.
Participants: Forty-seven patients seen in the GMC with confirmed DSD.
Results: Forty-seven patients met the inclusion criteria. The mean age of the patients at the time of GMT
evaluation was 9.1+/−6.1 years; 61.7% had male karyotype, and 38.3% had female karyotype; 51.1% had a male
external phenotype, 42.6% had a female external phenotype, and 6.4% had phenotypic ambiguity. Sex assignment
was concordant with genotype and phenotype in 63.8% and 86.4%, respectively of cases at the time of birth and in
76.6% and 97.7%, respectively, of cases after assessment by GMT.
Conclusion: Long-term outcomes are needed to establish standardized practice guidelines for decision-making.Introduction
Each year, approximately 1 in 3,000 infants is born with a
disorder of sexual differentiation (DSD). One of the many
challenges, and often a stressful one, particularly for par-
ents, is determining the sex assignment [1-4]. Because of
the paucity of studies on outcomes and decision-making
criteria that lead to satisfactory sex assignment, practice
guidelines for sex assignment have not yet been
established. Several clinical guidelines by our group [4]
and others [5] have been suggested. However, no previous
studies have explored the concordance of gender assign-
ment to genotype and/or phenotype as part of establishing
standardized guidelines. Our study goal was to retrospect-
ively assess patients with DSD in order to assess the cor-
relation of genotype and phenotype with sex assignment* Correspondence: jedietri@bcm.edu
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reproduction in any medium, provided the orboth before and after assessment by our Gender Medicine
Team (GMT).Methods
After obtaining IRB approval from Baylor College of
Medicine, Houston, Texas, we performed a retrospective
chart review of all patients treated in the Gender Medicine
Center (GMC) at Texas Children’s Hospital (TCH) in
Houston, Texas, between February 2006 and September
2009. The GMC is made up of Pediatric Endocrinology,
Pediatric Genetics, Pediatric Urology, Pediatric Gynecology,
Social Work, Psychology and Nursing. Inclusion criteria in-
cluded that patients were seen in the GMC at TCH and
had a confirmed DSD. This period preceded the use of an
established, ethically based guideline in our Center [6].
We reviewed the charts of 47 patients with DSD treated in
the GMC [4], with attention given specifically to history,
physical examination [7], hormonal tests, imaging studies
(ultrasound primarily, however, MRI was available in someLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Diagnostic features of cohort
Diagnosis Age range (years) N = 47 (%)
Hypospadius 1-7.75 9 (19.1)
Micropenis 4.5-5.75 4 (7.5)
MGD 0.5-25.75 9 (19.2)
VACTERL 10.75 1 (2.1)
AI 6-21.5 4 (8.5)
Turner 14-20.5 2 (4.3)
PMDS 9.75 1 (2.1)
CAH 4-20.5 8 (17)
Other 3.75-8.5 9 (19.2)
AIS: androgen insensitivity syndrome; CAH: congenital adrenal hyperplasia;
MGD: mixed gonadal dysgenesis; PAIS: Partial androgen insensitivity
syndrome; PMDS: persistent mullerian duct syndrome;, Other: endocrine or
anatomic syndromes, vanishing testes.
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genotype, the presence of a Y chromosome or partial Y
component was labeled as male genotype [8,9]. A decision
tree was used in the assessment and management of all
subjects with DSD. It included not only steps for ruling out
emergent endocrinopathies, but also specific detailed clin-
ical, laboratory, and karyotype assessments. Furthermore,
any interventions needed or sex assignment discrepancies
were further assessed to make final determinations about
sex assignment after the GMT evaluation was completed
(Figure 1). Patients were scheduled to be seen in the GMC
as soon as their Pedaitrician made a referral so the time
from evaluation at birth to evaluation in GMC was vari-
able. McNemar’s test and Kappa agreement provided asso-
ciations of various factors with sex assignment at birth and
after the GMT’s assessment.
Results
A total of 47 patients with a variety of underlying diagnos-
tic concerns were enrolled. The most common diagnosis
was mixed gonadal dysgenesis (19.2%), followed by hypo-
spadias (19.1%) and congenital adrenal hyperplasia (17%)
(Table 1). The mean age of the patients in the cohort was
8.6 yrs (SD +/− 6.14); 61.7% had male karyotype, and
38.3% had female karyotype. Mixed gonadal dysgenesis
was determined on the basis of phenotype and karyotype.
Of the 47 patients, 51.1% had external male phenotype,
42.6% had external female phenotype, and 6.4% had am-
biguous phenotype. Additional characteristics about phe-
notype were obtained from imaging studies. Evidence of
male internal organ anatomy was present in 30.4%. Evi-
dence of female internal organ anatomy was present in
30.4% of cases. Male and female structures were evidentFigure 1 Clinical algorithm for assessment of patients
with DSD.in 37% of cases, while no identifiable male or female
structures occurred in 2.2% of cases. At birth, 23.4%
reportedly had normal male hormonal patterns, and
76.6% had normal female hormonal patterns demon-
strated with biochemical testing. Further assessment
and biochemical testing by the GMT revealed that
46.8% had normal androgen (17 hydroxy progesterone,
dihydroepiandrostenedione, testosterone, dihydrotestos-
terone) patterns, 10.6% had no evidence of abnormal
androgens, and 42.6% had an intermediate pattern of an-
drogen secretion.
Sex assignment was concordant with genotype in
63.8% of cases at birth and in 76% of cases following
GMT assessment (Table 2). Similarly, phenotype was
concordant in 86.6% of cases at birth compared to 97.7%
concordance after GMT assessment (Table 3). Due to
small numbers, a trend in concordance of genotype and
phenotype with sex assignment was seen, although sta-
tistical significance was not confirmed (Tables 2 and 3).
Assessment of the individual features considered during
the process of sex assignment demonstrated that con-
cordance was higher following assessment by a GMT













9 (19.1%)* 6 (12.8%)*
Concordant 2 (4.3%)* 30 (63.8%)*
*McNemar p-value = 0.289.













0 (%)* 5 (11.4%)*
Concordant 1 (2.3%)* 38 (86.4%)*
*McNemar p-value = 0.219.
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Managing patients with DSD involves complex medical
and surgical challenges, as well as psychological and
social uncertainties that cannot always be anticipated at
the time of birth. This issue is not unique to this era of
medical care, as earlier literature suggested that gender
identity involved genetics, endocrinology, neurosurgery,
psychology, and anthropology [10]. It has also been sug-
gested that environmental agents (phytoestrogens) may
plays a role in gender identity, in addition to genetic and
hormonal influence [10]. Over the course of many
decades, the management of patients with DSD has
evolved to include a well-defined multidisciplinary team
in the complex decision-making process of sex assign-
ment [4,5]. An important component of our GMT
assessment at TCH is the education and engagement of
the parents in the decision-making process. We were one
of the first teams to include parental education and
involvement [4], which was a significant departure from
the old paternalistic approach whereby the physician made











Karyotype 46.8 53.2 0.371*
External anatomy 47.7 52.3 0.774*
Internal anatomy 42.9 57.1 0.571*











Karyotype 46.8 53.2 0.520*
External Anatomy 56.8 43.2 0.954*
Internal Anatomy 50.0 50.0 0.714*
**Hormones 63.0 37.0 0.557*
* Statistically significant at p < 0.05.
** Refers to hormonal testing to rule in or rule out presence of androgens.
Normal female and male levels in children were considered the normal
cut offs.important data for taking the next step in establishing
standardized management criteria. Our results suggest
that our approach yields more satisfactory results than
does the historical approach.
In spite of this and other advancements, the specific man-
agement is not clearly defined for each individual diagnosis,
and the challenge of establishing guidelines for making de-
cisions regarding sex assignment remains, partly due to the
paucity of outcomes data in this population. Redefining the
nomenclature used to refer to these patients in the context
of their genetic diagnosis [5] has provided some clarity and
was a step in the direction of standardization. Additionally,
the benefits of a comprehensive evaluation that includes
hormone, imaging, cytogenetic, and molecular studies
are well documented, as is the recognition that a team
approach is preferred. Finally, some patients may also bene-
fit from diagnostic laparoscopy and gonadal biopsy to aid in
the final sex determination when warranted. This series of
interventions, as well as parental involvement, is critical
toward establishing a standardized course of action that
will eventually lead to a successful outcome for each patient.
The objective of this retrospective chart review was to
compare the concordance of sex assignment as male or
female with genotype or phenotype based on the initial
presentation prior to GMT assessment and concordance
following GMT assessment. Our chart review of existing
patients demonstrates conclusively that sex assignment
does not correlate exactly with phenotypic or genotypic
features alone. The findings reported in this retrospective
analysis are important preliminary steps toward ongoing
studies to establish standardized management criteria.Conclusion
Decisions regarding sex of rearing in infants born with
ambiguous genitalia are challenging, yet critical toward
optimizing outcomes for these patients. To date, no data
are available to establish guidelines regarding sex assign-
ment, limiting the ability of a multidisciplinary team to
diagnose and treat complex conditions effectively. The
preliminary results of this study indicate that a greater cor-
relation exists between phenotype and final sex assign-
ment, which is important information for formulating
standardized practice guidelines and decision-making al-
gorithms in sex assignment among patients born with
DSD. The limitations of our study include the retrospect-
ive design and small numbers lending to some interpret-
ation bias. In addition, there were a variety of patients
with DSD, therefore, the power within groups was limited.
We plan to conduct further studies to ascertain the pre-
dictability of outcomes on the basis of sex assignment and
underlying conditions. This patient population would be-
nefit greatly from studies to assess patient satisfaction and
the risks and benefits of specific gender assignments.
Suresh et al. International Journal of Pediatric Endocrinology 2013, 2013:7 Page 4 of 4
http://www.ijpeonline.com/content/2013/1/7Competing interests
The authors declare that they have o competing interests.
Authors’ contributions
DS carried out the initial data collection on patients in the GMT clinic. JED
and LPK participated in the design of the study. DP and JC participated in
the initial draft and outline of the paper. OBS conducted all statistical
analyses. JED and LPK participated in the final review and edits to the
manuscript. All authors read and approved the final manuscript.
Acknowledgments
We are grateful to Dr Lee Ligon for her editorial contributions and to our
patients who provided us with the content of the paper.
Author details
1Department of Pediatrics, Gender Medicine Team, Baylor College of
Medicine, Houston, TX 77030, USA. 2Department of OBGYN, Division of
Pediatric and Adolescent Gynecology, Baylor College of Medicine, Houston,
TX 77030, USA. 3Department of Urology, Division of Pediatric Urology, Baylor
College of Medicine, Houston, TX 77030, USA.
Received: 5 November 2012 Accepted: 8 March 2013
Published: 14 March 2013
References
1. MacLaughlin DT, Donahoe PK: Sex determination and differentiation.
N Engl J Med 2004, 350(4):367–378.
2. Sultan C, Paris F, Jeandel C, et al: Ambiguous genitalia in the newborn:
diagnosis, etiology and sex assignment. Endocr Dev 2004, 7:23–38.
3. Hughes IA: Disorders of sex development: a new definition and
classification. Best Pract Res Clin Endocrinol Metab 2008, 22(1):119–134.
4. Axelrad ME, Berg JS, Coker LA, et al: The gender medicine team: “it takes a
village”. Adv Pediatr Infect Dis 2009, 56:145–164.
5. Lee PA, Houk CP, Ahmed FS, et al: Consensus statement on management
of intersex disorders. Pediatrics 2006, 118:3488.
6. Douglas G, Axelrad ME, Brandt ML, Crabtree E, Dietrich JE, French S, Gunn S,
Karaviti L, Lopez ME, Macias CG, McCullough LB, Suresh D, Sutton VR:
Consensus in guidelines for evaluation of DSD by Texas Children’s
hospital multidisciplinary gender medicine team. Int J Pediatr Endocrinol
2010. Epub 2010 Oct 17.
7. Arcari AJ, Bergada I, Rey RA, et al: Predictive value of anatomical findings
and karyotype analysis in the diagnosis of patients with disorders of
sexual development. Sex Dev 2007, 1(4):222–9.
8. Lu XY, Phung MT, Shaw CA, et al: Genomic imbalances in neonates with
birth defects: high detection rates by using chromosomal microarray
analysis. Pediatrics 2008, 122(6):1310–8.
9. Mendonca BB, Domenice S, Arnhold IJ, et al: 46, XY disorders of sex
development (DSD). Clin Endocrinol (Oxf ) 2009, 70(2):173–87.
10. Money J, Ehrhardt A: Man and woman, boy and girl: differentiation and
dimorphism of gender identity from conception to maturity. Johns Hopkins U.
Press; 1972.
doi:10.1186/1687-9856-2013-7
Cite this article as: Suresh et al.: Assessing sex assignment concordance
with genotype and phenotype. International Journal of Pediatric
Endocrinology 2013 2013:7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
